Shenzhen-based Main Luck Pharmaceuticals Co was granted an invention patent last week for its cancer medicine, the first of its kind in the nation. The invention provides a method to use cheap materials and eco-friendly techniques to compound belinostat, a substance widely believed to be the sole cure for some types of tumor. The medicine is also on the fast track for approval by the US Food and Drug Administration.

(Source: China Daily)